PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Nissen, Steven
TI  - Pioglitazone May Be Effective in Reducing Progression of Atherosclerosis in Patients with Diabetes
DP  - 2008 Jun 01
TA  - MD Conference Express
PG  - 15--15
VI  - 8
IP  - 2
4099  - http://mdc.sagepub.com/content/8/2/15.1.short
4100  - http://mdc.sagepub.com/content/8/2/15.1.full
AB  - Although coronary artery disease accounts for 75% of deaths in patients with diabetes, few studies have compared antidiabetic agents beyond their glucose-lowering efficacy. The prospective, randomized PERISCOPE trialtrial showed that an insulin-sensitizing drug (pioglitazone) may be more effective than a traditional insulin secretagogue (glimepiride) in stopping or reducing the progression of atherosclerosis.